Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Cano Health, Inc. (CANO : NYSE)
 
 • Company Description   
Cano Health Inc. is a value-based primary care provider for seniors and underserved communities. It provides health management programs including telehealth, prescription home delivery, wellness programs, transition of care and high-risk and complex care management. Cano Health Inc., formerly known as Jaws Acquisition Corp., is based in MIAMI.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $5.82 Daily Weekly Monthly
20 Day Moving Average: 3,231,923 shares
Shares Outstanding: 484.47 (millions)
Market Capitalization: $2,819.62 (millions)
Beta: 1.22
52 Week High: $16.17
52 Week Low: $3.81
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 6.20% 12.50%
12 Week 8.79% 18.85%
Year To Date -34.68% -21.01%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
9725 NW 117TH AVENUE SUITE 200
-
MIAMI,FL 33178
USA
ph: 855-226-6633
fax: -
investors@canohealth.com http://www.canohealth.com
 
 • General Corporate Information   
Officers
Marlow Hernandez - Chief Executive Officer
Brian D. Koppy - Chief Financial Officer
Mark Novell - Chief Accounting Officer
Lewis Gold - Director
Jacqui Guichelaar - Director

Peer Information
Cano Health, Inc. (CHCR)
Cano Health, Inc. (ESRX)
Cano Health, Inc. (MYDP)
Cano Health, Inc. (GBCS)
Cano Health, Inc. (LAXAF)
Cano Health, Inc. (IPCM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 13781Y103
SIC: 8011
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/11/22
Share - Related Items
Shares Outstanding: 484.47
Most Recent Split Date: (:1)
Beta: 1.22
Market Capitalization: $2,819.62 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.03 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.07 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/11/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 3.37
Price/Cash Flow: 126.94
Price / Sales: 1.33
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 41.67%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 43.08%
ROE
03/31/22 - -6.66
12/31/21 - -7.02
09/30/21 - -20.96
ROA
03/31/22 - -2.78
12/31/21 - -2.70
09/30/21 - -7.40
Current Ratio
03/31/22 - 2.04
12/31/21 - 1.97
09/30/21 - 3.33
Quick Ratio
03/31/22 - 2.04
12/31/21 - 1.96
09/30/21 - 3.32
Operating Margin
03/31/22 - -2.66
12/31/21 - -2.53
09/30/21 - -5.80
Net Margin
03/31/22 - -0.55
12/31/21 - -1.68
09/30/21 - -4.90
Pre-Tax Margin
03/31/22 - -4.74
12/31/21 - -7.25
09/30/21 - -7.91
Book Value
03/31/22 - 1.73
12/31/21 - 1.67
09/30/21 - 1.80
Inventory Turnover
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Equity
03/31/22 - 1.10
12/31/21 - 1.15
09/30/21 - 1.07
Debt-to-Capital
03/31/22 - 52.30
12/31/21 - 53.48
09/30/21 - 51.68
 

Powered by Zacks Investment Research ©